Tumor marker usage and medical care costs among older early-stage breast cancer survivors.
about
Identification of Biomarkers for Breast Cancer Using Databases.Overuse of Health Care Services in the Management of Cancer: A Systematic Review.Use of CEA and CA15-3 to Predict Axillary Lymph Node Metastasis in Patients with Breast CancerIncidental radiologic findings at breast cancer diagnosis and likelihood of disease recurrence.Serum Tumor Marker Use in Patients With Advanced Solid Tumors.Use and Costs of Disease Monitoring in Women With Metastatic Breast Cancer.Targeting Ewing sarcoma with activated and GD2-specific chimeric antigen receptor-engineered human NK cells induces upregulation of immune-inhibitory HLA-G.Association between survival time with metastatic breast cancer and aggressive end-of-life care.Use of posttreatment imaging and biomarkers in survivors of early-stage breast cancer: Inappropriate surveillance or necessary care?Detection of survivin, carcinoembryonic antigen and ErbB2 level in oral squamous cell carcinoma patients.Analysis of blood markers for early breast cancer diagnosis.Extent and cost of inappropriate use of tumour markers in patients with pulmonary disease: a multicentre retrospective study in Shanghai, China.Clinicopathological and Prognostic Significance of Cancer Antigen 15-3 and Carcinoembryonic Antigen in Breast Cancer: A Meta-Analysis including 12,993 Patients.
P2860
Q30239810-EAAD4584-12AC-4274-AE04-6BF945435B96Q36370093-E8A38D88-4517-4754-9FE1-23E87017C437Q36372403-2213F7A6-A267-4E19-9AC5-AC12CF79852AQ36526137-D05AB499-7AD7-4520-A44B-9B1A6E93C23DQ37157669-28D63875-719F-488F-8307-8A1B1244C2E0Q37234788-3F040FD0-D1F5-42ED-BE2C-3F4187227874Q39135703-E329B472-0237-47FE-86FA-6634F16DE806Q40104641-73E8A101-A5D9-4D42-8BC5-33CB66DC867AQ40228943-DB48DE08-BE59-4AF3-8A05-0CFEC28ED102Q47679320-9DB4E46C-6187-4839-A7F1-A5D2DBA7077BQ47725879-5ABBF003-1D39-4F0F-9E0D-777FE53235D4Q55020662-2EFD5197-C857-4667-A773-750949D8AEE2Q55036428-B7802FDE-EAF2-4F72-B641-55CD68B73F54
P2860
Tumor marker usage and medical care costs among older early-stage breast cancer survivors.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Tumor marker usage and medical ...... stage breast cancer survivors.
@ast
Tumor marker usage and medical ...... stage breast cancer survivors.
@en
Tumor marker usage and medical ...... stage breast cancer survivors.
@nl
type
label
Tumor marker usage and medical ...... stage breast cancer survivors.
@ast
Tumor marker usage and medical ...... stage breast cancer survivors.
@en
Tumor marker usage and medical ...... stage breast cancer survivors.
@nl
prefLabel
Tumor marker usage and medical ...... stage breast cancer survivors.
@ast
Tumor marker usage and medical ...... stage breast cancer survivors.
@en
Tumor marker usage and medical ...... stage breast cancer survivors.
@nl
P2093
P2860
P356
P1476
Tumor marker usage and medical ...... stage breast cancer survivors.
@en
P2093
Dana K Mirick
David L Veenstra
David Mummy
Julie R Gralow
N Lynn Henry
Rahber Thariani
Ruth Etzioni
Scott D Ramsey
William Barlow
P2860
P304
P356
10.1200/JCO.2014.55.5409
P407
P577
2014-10-20T00:00:00Z